Genetics and epigenetics of circadian rhythms and their potential roles in neuropsychiatric disorders

Neuroscience Bulletin

Volumn 31, Issue 1, 2015, Pages 141-159

  Liu, Chunyu ^a,b   Chung, Michael ^b  

^a State Key Laboratory of Medical Genetics of China   (China)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Circadian rhythms; Epigenetics; Neuropsychiatry

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA3; CRYPTOCHROME; DICER; DNA; DOPAMINE 2 RECEPTOR; E1A ASSOCIATED P300 PROTEIN; MELATONIN; MICRORNA; NUCLEAR RECEPTOR NR1D1; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; PROTEIN TIMELESS; RETINOIC ACID RECEPTOR ALPHA; RNA; TRANSCRIPTION FACTOR ARNTL;

ACETYLATION; ALCOHOL CONSUMPTION; ANXIETY DISORDER; BIPOLAR DISORDER; CIRCADIAN RHYTHM; DEACETYLATION; DEPRESSION; DISEASE ASSOCIATION; DNA METHYLATION; ENERGY BALANCE; EPIGENETICS; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC VARIABILITY; HEROIN DEPENDENCE; HOMEOSTASIS; HUMAN; INSOMNIA; JET LAG; MAJOR DEPRESSION; MOOD DISORDER; NARCOLEPSY; NEUROPATHOLOGY; NEUROPSYCHIATRIC DISORDER; NEUROPSYCHIATRY; NEUROSIS; NONHUMAN; PROTEIN FUNCTION; REVIEW; RNA PROCESSING; SCHIZOPHRENIA; SEASONAL AFFECTIVE DISORDER; SHIFT WORKER; SLEEP DISORDER; SLEEP TIME; SLEEP WAKING CYCLE; SUBSTANCE ABUSE; SUPRACHIASMATIC NUCLEUS; ANIMAL; CIRCADIAN RHYTHM SLEEP DISORDER; COMPLICATION; GENETIC EPIGENESIS; GENETICS; MENTAL DISEASE; PATHOPHYSIOLOGY;

ANIMALS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; EPIGENESIS, GENETIC; HUMANS; MENTAL DISORDERS; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 84922371985     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-014-1495-3     Document Type: Review

References (208)

1. Honma K, Honma S, Wada T. Entrainment of human circadian rhythms by artificial bright light cycles. Experientia 1987, 43: 572–574.
2. Buhr ED, Yoo SH, Takahashi JS. Temperature as a universal resetting cue for mammalian circadian oscillators. Science 2010, 330: 379–385.
3. Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J 2012, 26: 3493–3502.
4. Abraham U, Saleh M, Kramer A. Odor is a time cue for circadian behavior. J Biol Rhythms 2013, 28: 26–37.
5. Fuller CA, Hoban-Higgins TM, Griffin DW, Murakami DM. Influence of gravity on the circadian timing system. Adv Space Res 1994, 14: 399–408.
6. Bailey SM, Udoh US, Young ME. Circadian regulation of metabolism. J Endocrinol 2014, 222: R75–R96.
7. Morris CJ, Yang JN, Scheer FA. The impact of the circadian timing system on cardiovascular and metabolic function. Prog Brain Res 2012, 199: 337–358.
8. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, et al. Circadian rhythms in isolated brain regions. J Neurosci 2002, 22: 350–356.
9. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res 2002, 309: 193–199.
10. Leise TL, Wang CW, Gitis PJ, Welsh DK. Persistent cell-autonomous circadian oscillations in fibroblasts revealed by six-week single-cell imaging of PER2::LUC bioluminescence. PLoS One 2012, 7: e33334.
11. Ruan GX, Allen GC, Yamazaki S, McMahon DG. An autonomous circadian clock in the inner mouse retina regulated by dopamine and GABA. PLoS Biol 2008, 6: e249.
12. Hughes ME, Hong HK, Chong JL, Indacochea AA, Lee SS, Han M, et al. Brain-specific rescue of Clock reveals systemdriven transcriptional rhythms in peripheral tissue. PLoS Genet 2012, 8: e1002835.
13. Wager-Smith K, Kay SA. Circadian rhythm genetics: from flies to mice to humans. Nat Genet 2000, 26: 23–27.
14. Gachon F, Olela FF, Schaad O, Descombes P, Schibler U. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab 2006, 4: 25–36.
15. Mitsui S, Yamaguchi S, Matsuo T, Ishida Y, Okamura H. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev 2001, 15: 995–1006.
16. Jetten AM, Kurebayashi S, Ueda E. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog Nucleic Acid Res Mol Biol 2001, 69: 205–247.
17. Obrietan K, Impey S, Smith D, Athos J, Storm DR. Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J Biol Chem 1999, 274: 17748–17756.
18. Buhr ED, Takahashi JS. Molecular components of the Mammalian circadian clock. Handb Exp Pharmacol 2013, (217): 3–27.
19. Brown SA, Azzi A. Peripheral circadian oscillators in mammals. Handb Exp Pharmacol 2013, (217): 45–66.
20. Bozek K, Relogio A, Kielbasa SM, Heine M, Dame C, Kramer A, et al. Regulation of clock-controlled genes in mammals. PLoS One 2009, 4: e4882.
21. Kumaki Y, Ukai-Tadenuma M, Uno KD, Nishio J, Masumoto KH, Nagano M, et al. Analysis and synthesis of high-amplitude Cis-elements in the mammalian circadian clock. Proc Natl Acad Sci U S A 2008, 105: 14946–14951.
22. Bozek K, Kielbasa SM, Kramer A, Herzel H. Promoter analysis of Mammalian clock controlled genes. Genome Inform 2007, 18: 65–74.
23. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG, et al. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 2002, 12: 540–550.
24. Kornmann B, Preitner N, Rifat D, Fleury-Olela F, Schibler U. Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs. Nucleic Acids Res 2001, 29: E51.
25. Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A 2007, 104: 3342–3347.
26. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002, 109: 307–320.
27. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002, 417: 78–83.
28. Storch KF, Paz C, Signorovitch J, Raviola E, Pawlyk B, Li T, et al. Intrinsic circadian clock of the mammalian retina: importance for retinal processing of visual information. Cell 2007, 130: 730–741.
29. Leonardson AS, Zhu J, Chen Y, Wang K, Lamb JR, Reitman M, et al. The effect of food intake on gene expression in human peripheral blood. Hum Mol Genet 2010, 19: 159–169.
30. Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A 2013, 110: 9950–9955.
31. Lim AS, Srivastava GP, Yu L, Chibnik LB, Xu J, Buchman AS, et al. 24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex. PLoS Genet 2014, 10: e1004792.
32. Yan J, Wang H, Liu Y, Shao C. Analysis of gene regulatory networks in the mammalian circadian rhythm. PLoS Comput Biol 2008, 4: e1000193.
33. Goriki A, Hatanaka F, Myung J, Kim JK, Yoritaka T, Tanoue S, et al. A novel protein, CHRONO, functions as a core component of the mammalian circadian clock. PLoS Biol 2014, 12: e1001839
34. Anafi RC, Lee Y, Sato TK, Venkataraman A, Ramanathan C, Kavakli IH, Hughes ME, Baggs JE, Growe J, Liu AC, et al. Machine learning helps identify CHRONO as a circadian clock component. PLoS Biol 2014, 12: e1001840.
35. Gossan NC, Zhang F, Guo B, Jin D, Yoshitane H, Yao A, et al. The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res 2014, 42: 5765–5775.
36. Jouffe C, Cretenet G, Symul L, Martin E, Atger F, Naef F, et al. The circadian clock coordinates ribosome biogenesis. PLoS Biol 2013, 11: e1001455.
37. Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 2009, 139: 199–210.
38. Podobed PS, Kirby GM, Martino TA. Circadian Proteomics and Its Unique Advantage for Discovery of Biomarkers of Heart Disease. In: Tsz Kwong Man, editor. Proteomics - Human Diseases and Protein Functions. InTech, 2012.
39. Mehra A, Baker CL, Loros JJ, Dunlap JC. Post-translational modifications in circadian rhythms. Trends Biochem Sci 2009, 34: 483–490.
40. Moller M, Lund-Andersen C, Rovsing L, Sparre T, Bache N, Roepstorff P, et al. Proteomics of the photoneuroendocrine circadian system of the brain. Mass Spectrom Rev 2010, 29: 313–325.
41. Mauvoisin D, Dayon L, Gachon F, Kussmann M. Proteomics and circadian rhythms: It’s all about signaling! Proteomics. 2014
42. Klei L, Reitz P, Miller M, Wood J, Maendel S, Gross D, et al. Heritability of morningness-eveningness and self-report sleep measures in a family-based sample of 521 hutterites. Chronobiol Int 2005, 22: 1041–1054.
43. Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, et al. A CLOCK polymorphism associated with human diurnal preference. Sleep 1998, 21: 569–576.
44. Allebrandt KV, Amin N, Muller-Myhsok B, Esko T, Teder-Laving M, Azevedo RV, et al. A K(ATP) channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila. Mol Psychiatry 2013, 18: 122–132.
45. Silver R, Kriegsfeld LJ. Circadian rhythms have broad implications for understanding brain and behavior. Eur J Neurosci 2014, 39: 1866–1880.
46. Huang W, Ramsey KM, Marcheva B, Bass J. Circadian rhythms, sleep, and metabolism. J Clin Invest 2011, 121: 2133–2141.
47. Barclay JL, Husse J, Bode B, Naujokat N, Meyer-Kovac J, Schmid SM, et al. Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS One 2012, 7: e37150.
48. Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res 2010, 106: 447–462.
49. Froy O. Metabolism and circadian rhythms—implications for obesity. Endocr Rev 2010, 31: 1–24.
50. Nagorny C, Lyssenko V. Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story? Curr Diab Rep 2012, 12: 667–672.
51. Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol 2011, 7: 29–36.
52. Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med 2012, 18: 1249–1260.
53. Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 2007, 47: 593–628.
54. Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol 2011, 57: 249–256.
55. Lamont EW, Coutu DL, Cermakian N, Boivin DB. Circadian rhythms and clock genes in psychotic disorders. Isr J Psychiatry Relat Sci 2010, 47: 27–35.
56. Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci 2007, 9: 333–342.
57. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 2010, 11: 589–599.
58. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007, 30: 873–880.
59. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989, 262: 1479–1484.
60. Roane BM, Taylor DJ. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep 2008, 31: 1351–1356.
61. Shibley HL, Malcolm RJ, Veatch LM. Adolescents with insomnia and substance abuse: consequences and comorbidities SHIBLEY2008. J Psychiatr Pract 2008, 14: 146–153.
62. Armstrong SM, Cassone VM, Chesworth MJ, Redman JR, Short RV. Synchronization of mammalian circadian rhythms by melatonin. J.Neural Transm.Suppl 1986, 21: 375–394.
63. de BC, Guardiola-Lemaitre B, Mocaer E, Renard P, Munoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010, 9: 628–642.
64. Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 2010, 71: 109–120.
65. Bellet MM, Vawter MP, Bunney BG, Bunney WE, Sassone-Corsi P. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One 2011, 6: e23982.
66. Li SX, Liu LJ, Xu LZ, Gao L, Wang XF, Zhang JT, et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology 2013, 38: 2789–2799.
67. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 2007, 104: 6406–6411.
68. Oliver PL, Sobczyk MV, Maywood ES, Edwards B, Lee S, Livieratos A, et al. Disrupted circadian rhythms in a mouse model of schizophrenia. Curr Biol 2012, 22: 314–319.
69. Gorwood P. Anxiety disorders and circadian rhythms. Medicographia 2012, 34: 289–294.
70. Wong CC, Schumann G. Integration of the circadian and stress systems: influence of neuropeptides and implications for alcohol consumption. J Neural Transm 2012, 119: 1111–1120.
71. Landgraf D, McCarthy MJ, Welsh DK. Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep 2014, 16: 483.
72. Doi M, Yujnovsky I, Hirayama J, Malerba M, Tirotta E, Sassone-Corsi P, et al. Impaired light masking in dopamine D2 receptor-null mice DOI2006. Nat Neurosci 2006, 9: 732–734.
73. Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, et al. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet 2014, 78: 33–39.
74. Li MD, Burmeister M. New insights into the genetics of addiction. Nat Rev Genet 2009, 10: 225–231.
75. Wang F, Simen A, Arias A, Lu QW, Zhang H. A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet 2013, 132: 347–358.
76. Olfson E, Bierut LJ. Convergence of genome-wide association and candidate gene studies for alcoholism. Alcohol Clin Exp Res 2012, 36: 2086–2094.
77. Sipila T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD, et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry 2010, 67: 1163–1170.
78. Wing YK, Zhang J, Lam SP, Li SX, Tang NL, Lai KY, et al. Familial aggregation and heritability of insomnia in a community-based study. Sleep Med 2012, 13: 985–990.
79. McCarren M, Goldberg J, Ramakrishnan V, Fabsitz R. Insomnia in Vietnam era veteran twins: influence of genes and combat experience. Sleep 1994, 17: 456–461.
80. Watson NF, Goldberg J, Arguelles L, Buchwald D. Genetic and environmental influences on insomnia, daytime sleepiness, and obesity in twins. Sleep 2006, 29: 645–649.
81. Palagini L, Biber K, Riemann D. The genetics of insomnia—evidence for epigenetic mechanisms? Sleep Med Rev 2014, 18: 225–235.
82. Manfredi RL, Brennan RW, Cadieux RJ. Disorders of excessive sleepiness: narcolepsy and hypersomnia. Semin Neurol 1987, 7: 250–258.
83. Buysse DJ. Insomnia. JAMA 2013, 309: 706–716.
84. Longstreth WT, Jr., Koepsell TD, Ton TG, Hendrickson AF, van BG. The epidemiology of narcolepsy. Sleep 2007, 30: 13–26.
85. Buhr A, Bianchi MT, Baur R, Courtet P, Pignay V, Boulenger JP, et al. Functional characterization of the new human GABA(A) receptor mutation beta3(R192H). Hum Genet 2002, 111: 154–160.
86. Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci.Transl. Med. 2012, 4: 161ra151.
87. Wurtman RJ. Narcolepsy and the hypocretins. Metabolism 2006, 55(10 Suppl 2): S36–S39.
88. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001, 291: 1040–1043.
89. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005, 434: 640–644.
90. Punia S, Rumery KK, Yu EA, Lambert CM, Notkins AL, Weaver DR. Disruption of gene expression rhythms in mice lacking secretory vesicle proteins IA-2 and IA-2beta. Am J Physiol Endocrinol Metab 2012, 303: E762–E776.
91. Zhang EE, Kay SA. Clocks not winding down: unravelling circadian networks. Nat Rev Mol Cell Biol 2010, 11: 764–776.
92. Byrne EM, Gehrman PR, Medland SE, Nyholt DR, Heath AC, Madden PA, et al. A genome-wide association study of sleep habits and insomnia. Am J Med Genet B Neuropsychiatr Genet 2013, 162B: 439–451.
93. Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 2011, 7: e1002171.
94. Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008, 40: 946–948.
95. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39: 1000–1006.
96. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357: 639–647.
97. Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009, 41: 708–711.
98. Etain B, Jamain S, Milhiet V, Lajnef M, Boudebesse C, Dumaine A, et al. Association between circadian genes, bipolar disorders and chronotypes. Chronobiol Int 2014, 31: 807–814.
99. Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, et al. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet 2008, 147B: 1047–1055.
100. Kripke DF, Nievergelt CM, Tranah GJ, Murray SS, Rex KM, Grizas AP, et al. FMR1, circadian genes and depression: suggestive associations or false discovery? J Circadian Rhythms 2013, 11: 3.
101. Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppa T, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 2003, 28: 734–739.
102. Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 2007, 39: 229–238.
103. Kovanen L, Saarikoski ST, Haukka J, Pirkola S, Aromaa A, Lonnqvist J, et al. Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Alcohol Alcohol 2010, 45: 303–311.
104. Levran O, Londono D, O’Hara K, Nielsen DA, Peles E, Rotrosen J, et al. Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 2008, 7: 720–729.
105. Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, et al. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord 2009, 11: 701–710.
106. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 2010, 35: 1279–1289.
107. Utge SJ, Soronen P, Loukola A, Kronholm E, Ollila HM, Pirkola S, et al. Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance. PLoS One 2010, 5: e9259.
108. McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS One 2012, 7: e32091.
109. Wetherill L, Agrawal A, Kapoor M, Bertelsen S, Bierut LJ, Brooks A, et al. Association of substance dependence phenotypes in the COGA sample. Addict.Biol 2014
110. Schosser A, Butler AW, Uher R, Ng MY, Cohen-Woods S, Craddock N, et al. Genome-wide association study of co-occurring anxiety in major depression. World J Biol Psychiatry 2013, 14: 611–621.
111. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45: 984–994.
112. Trzaskowski M, Eley TC, Davis OS, Doherty SJ, Hanscombe KB, Meaburn EL, et al. First genome-wide association study on anxiety-related behaviours in childhood. PLoS One 2013, 8: e58676.
113. Chen X, Cho K, Singer BH, Zhang H. The nuclear transcription factor PKNOX2 is a candidate gene for substance dependence in European-origin women. PLoS One 2011, 6: e16002.
114. Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 2003, 421: 177–182.
115. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006, 125: 497–508.
116. Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, et al. CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature 2007, 450: 1086–1090.
117. Johansson AS, Brask J, Owe-Larsson B, Hetta J, Lundkvist GB. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. J Biol Rhythms 2011, 26: 541–551.
118. Alenghat T, Meyers K, Mullican SE, Leitner K, iji-Adele A, Avila J, et al. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 2008, 456: 997–1000.
119. Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011, 331: 1315–1319.
120. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134: 317–328.
121. Gan L, Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008, 58: 10–14.
122. Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 2013, 153: 1448–1460.
123. Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010, 30: 9695–9707.
124. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466: 1105–1109.
125. DiTacchio L, Le HD, Vollmers C, Hatori M, Witcher M, Secombe J, et al. Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. Science 2011, 333: 1881–1885.
126. Bonsch D, Hothorn T, Krieglstein C, Koch M, Nehmer C, Lenz B, et al. Daily variations of homocysteine concentration may influence methylation of DNA in normal healthy individuals. Chronobiol Int 2007, 24: 315–326.
127. Krishna SM, Dear A, Craig JM, Norman PE, Golledge J. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis 2013, 228: 295–305.
128. Azzi A, Dallmann R, Casserly A, Rehrauer H, Patrignani A, Maier B, et al. Circadian behavior is light-reprogrammed by plastic DNA methylation. Nat Neurosci 2014, 17: 377–382.
129. Massart R, Freyburger M, Suderman M, Paquet J, El HJ, Belanger-Nelson E, et al. The genome-wide landscape of DNA methylation and hydroxymethylation in response to sleep deprivation impacts on synaptic plasticity genes. Transl Psychiatry 2014, 4: e347.
130. Chen R, D’Alessandro M, Lee C. miRNAs are required for generating a time delay critical for the circadian oscillator. Curr Biol 2013, 23: 1959–1968.
131. Cheng HY, Papp JW, Varlamova O, Dziema H, Russell B, Curfman JP, et al. microRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54: 813–829.
132. Varez-Saavedra M, Antoun G, Yanagiya A, Oliva-Hernandez R, Cornejo-Palma D, Perez-Iratxeta C, et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet 2011, 20: 731–751.
133. Coon SL, Munson PJ, Cherukuri PF, Sugden D, Rath MF, Moller M, et al. Circadian changes in long noncoding RNAs in the pineal gland. Proc Natl Acad Sci U S A 2012, 109: 13319–13324.
134. Xue Z, Ye Q, Anson SR, Yang J, Xiao G, Kowbel D, et al. Transcriptional interference by antisense RNA is required for circadian clock function. Nature 2014
135. Hughes ME, Grant GR, Paquin C, Qian J, Nitabach MN. Deep sequencing the circadianand diurnal transcriptome of Drosophila brain HUGHES2012. Genome Res 2012, 22: 1266–1281.
136. Johnsson P, Lipovich L, Grander D, Morris KV. Evolutionary conservation of long non-coding RNAs, sequence, structure, function. Biochim Biophys Acta 2014, 1840: 1063–1071.
137. Pang KC, Frith MC, Mattick JS. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet 2006, 22: 1–5.
138. Fustin JM, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 2013, 155: 793–806.
139. Suter M, Bocock P, Showalter L, Hu M, Shope C, McKnight R, et al. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J 2011, 25: 714–726.
140. Ciarleglio CM, Axley JC, Strauss BR, Gamble KL, McMahon DG. Perinatal photoperiod imprints the circadian clock CIARLEGLIO2011. Nat Neurosci 2011, 14: 25–27.
141. Chavez SL, McElroy SL, Bossert NL, De Jonge CJ, Rodriguez MV, Leong DE, et al. Comparison of epigenetic mediator expression and function in mouse and human embryonic blastomeres. Hum Mol Genet 2014, 23: 4970–4984.
142. Moller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A 2013, 110: E1132–E1141.
143. Archer SN, Laing EE, Moller-Levet CS, van d, V, Bucca G, Lazar AS, et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci U S A 2014, 111: E682–E691.
144. Bollati V, Baccarelli A, Sartori S, Tarantini L, Motta V, Rota F, et al. Epigenetic effects of shiftwork on blood DNA methylation. Chronobiol Int 2010, 27: 1093–1104.
145. Dykens E, Shah B. Psychiatric disorders in Prader-Willi syndrome: epidemiology and management. CNS Drugs 2003, 17: 167–178.
146. Sahoo T, del GD, German JR, Shinawi M, Peters SU, Person RE, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 2008, 40: 719–721.
147. Powell WT, Coulson RL, Crary FK, Wong SS, Ach RA, Tsang P, et al. A Prader-Willi locus lncRNA cloud modulates diurnal genes and energy expenditure. Hum Mol Genet 2013, 22: 4318–4328.
148. Saus E, Soria V, Escaramis G, Vivarelli F, Crespo JM, Kagerbauer B, et al. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. Hum Mol Genet 2010, 19: 4017–4025.
149. Grennan KS, Chen C, Gershon ES, Liu C. Molecular network analysis enhances understanding of the biology of mental disorders. Bioessays 2014, 36: 606–616.
150. Hayes KR, Baggs JE, Hogenesch JB. Circadian clocks are seeing the systems biology light. Genome Biol 2005, 6: 219.
151. Patel VR, Eckel-Mahan K, Sassone-Corsi P, Baldi P. CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics. Nat Methods 2012, 9: 772–773.
152. Ukai H, Ueda HR. Systems biology of mammalian circadian clocks. Annu Rev Physiol 2010, 72: 579–603.
153. McDonald MJ, Rosbash M. Microarray analysis and organization of circadian gene expression in Drosophila. Cell 2001, 107: 567–578.
154. Ueda HR. A systems-biological approach in drug discovery for circadian rhythm disorders. Nihon Yakurigaku Zasshi 2002, 120: 37P–40P.
155. Zvonic S, Ptitsyn AA, Conrad SA, Scott LK, Floyd ZE, Kilroy G, et al. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 2006, 55: 962–970.
156. Oster H, Damerow S, Hut RA, Eichele G. Transcriptional profiling in the adrenal gland reveals circadian regulation of hormone biosynthesis genes and nucleosome assembly genes. J Biol Rhythms 2006, 21: 350–361.
157. Lemos DR, Downs JL, Urbanski HF. Twenty-four-hour rhythmic gene expression in the rhesus macaque adrenal gland. Mol Endocrinol 2006, 20: 1164–1176.
158. Zvonic S, Ptitsyn AA, Kilroy G, Wu X, Conrad SA, Scott LK, et al. Circadian oscillation of gene expression in murine calvarial bone. J Bone Miner Res 2007, 22: 357–365.
159. Yang S, Wang K, Valladares O, Hannenhalli S, Bucan M. Genome-wide expression profiling and bioinformatics analysis of diurnally regulated genes in the mouse prefrontal cortex. Genome Biol 2007, 8: R247.
160. Maret S, Dorsaz S, Gurcel L, Pradervand S, Petit B, Pfister C, et al. Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci U S A 2007, 104: 20090–20095.
161. Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol 2008, 294: H1036–H1047.
162. Kronfeld-Schor N, Einat H. Circadian rhythms and depression: human psychopathology and animal models. Neuropharmacology 2012, 62: 101–114.
163. Mendlewicz J, Kerkhofs M. Sleep electroencephalography in depressive illness. A collaborative study by the World Health Organization. Br J Psychiatry 1991, 159: 505–509.
164. Kupfer DJ. REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry 1976, 11: 159–174.
165. Emens J, Lewy A, Kinzie JM, Arntz D, Rough J. Circadian misalignment in major depressive disorder. Psychiatry Res 2009, 168: 259–261.
166. Robillard R, Naismith SL, Hickie IB. Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder. Curr Psychiatry Rep 2013, 15: 402.
167. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry 2008, 165: 830–843.
168. Monk TH, Burk LR, Klein MH, Kupfer DJ, Soehner AM, Essex MJ. Behavioral circadian regularity at age 1 month predicts anxiety levels during school-age years. Psychiatry Res 2010, 178: 370–373.
169. Shibley HL, Malcolm RJ, Veatch LM. Adolescents with insomnia and substance abuse: consequences and comorbidities SHIBLEY2008. J Psychiatr Pract 2008, 14: 146–153.
170. Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci 2000, 25: 469–480.
171. Leibenluft E, Wehr TA. Is sleep deprivation useful in the treatment of depression? Am J Psychiatry 1992, 149: 159–168.
172. Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res 1999, 86: 267–270.
173. Iwahana E, Hamada T, Uchida A, Shibata S. Differential effect of lithium on the circadian oscillator in young and old hamsters. Biochem Biophys Res Commun. 2007, 354: 752–756.
174. McCarthy MJ, Wei H, Marnoy Z, Darvish RM, McPhie DL, Cohen BM, et al. Genetic and clinical factors predict lithium’s effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry 2013, 3: e318.
175. Osland TM, Ferno J, Havik B, Heuch I, Ruoff P, Laerum OD, et al. Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. J Psychopharmacol 2011, 25: 924–933.
176. Demyttenaere K. Agomelatine in treating generalized anxiety disorder. Expert Opin Investig Drugs 2014, 23: 857–864.
177. Stein DJ, Ahokas A, Marquez MS, Hoschl C, Oh KS, et al. Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. J Clin Psychiatry 2014, 75: 362–368.
178. Mansour HA, Wood J, Chowdari KV, Dayal M, Thase ME, Kupfer DJ, et al. Circadian phase variation in bipolar I disorder. Chronobiol Int 2005, 22: 571–584.
179. Wood J, Birmaher B, Axelson D, Ehmann M, Kalas C, Monk K, et al. Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals. Psychiatry Res 2009, 166(2–3): 201–209.
180. Broms U, Pennanen M, Patja K, Ollila H, Korhonen T, Kankaanpaa A, et al. Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study. J Addict Res Ther 2012, S2
181. Adan A. Chronotype and personality factors in the daily consumption of alcohol and psychostimulants. Addiction 1994, 89: 455–462.
182. Malkoff-Schwartz S, Frank E, Anderson BP, Hlastala SA, Luther JF, Sherrill JT, et al. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med 2000, 30: 1005–1016.
183. Ashman SB, Monk TH, Kupfer DJ, Clark CH, Myers FS, Frank E, Leibenluft. Relationship between social rhythms and mood in patients with rapid cycling bipolar disorder. Psychiatry Res 1999, 86: 1–8.
184. Malkoff-Schwartz S, Frank E, Anderson B, Sherrill JT, Siegel L, Patterson D, et al. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch Gen Psychiatry 1998, 55: 702–707.
185. Shear MK, Randall J, Monk TH, Ritenour A, Tu X, Frank E, et al. Social rhythm in anxiety disorder patients. Anxiety 1994, 1: 90–95.
186. Cassidy F, Carroll BJ. Seasonal variation of mixed and pure episodes of bipolar disorder. J Affect Disord 2002, 68: 25–31.
187. Silverstone T, Romans S, Hunt N, McPherson H. Is there a seasonal pattern of relapse in bipolar affective disorders? A dual northern and southern hemisphere cohort study. Br J Psychiatry 1995, 167: 58–60.
188. Sandyk R, Kanofsky JD. Cocaine addiction: relationship to seasonal affective disorder. Int J Neurosci 1992, 64(1–4): 195–201.
189. Nurnberger JI, Jr., Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry 2000, 57: 572–579.
190. Lewy AJ, Nurnberger JI, Jr., Wehr TA, Pack D, Becker LE, Powell RL, et al. Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry 1985, 142: 725–727.
191. Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004, 18: 314–325.
192. Lovallo WR. Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 2006, 59: 195–202.
193. Gonzalez R. The relationship between bipolar disorder and biological rhythms. J Clin Psychiatry 2014, 75: e323–e331.
194. Sipila T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD, et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry 2010, 67: 1163–1170.
195. Blomeyer D, Buchmann AF, Lascorz J, Zimmermann US, Esser G, Desrivieres S, et al. Association of PER2 genotype and stressful life events with alcohol drinking in young adults. PLoS One 2013, 8: e59136.
196. Shumay E, Fowler JS, Wang GJ, Logan J, ia-Klein N, Goldstein RZ, et al. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability. Transl Psychiatry 2012, 2: e86.
197. Dong L, Bilbao A, Laucht M, Henriksson R, Yakovleva T, Ridinger M, et al. Effects of the circadian rhythm gene period 1 (per1) on psychosocial stress-induced alcohol drinking. Am J Psychiatry 2011, 168: 1090–1098.
198. Comasco E, Nordquist N, Gokturk C, Aslund C, Hallman J, Oreland L, et al. The clock gene PER2 and sleep problems: association with alcohol consumption among Swedish adolescents. Ups J Med Sci 2010, 115: 41–48.
199. Malison RT, Kranzler HR, Yang BZ, Gelernter J. Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia. Psychiatr Genet 2006, 16: 245–249.
200. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 2005, 11: 35–42.
201. Chung S, Lee EJ, Yun S, Choe HK, Park SB, Son HJ, et al. Impact of circadian nuclear receptor REV-ERBalpha on midbrain dopamine production and mood regulation. Cell 2014, 157: 858–868.
202. Spencer S, Falcon E, Kumar J, Krishnan V, Mukherjee S, Birnbaum SG, et al. Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. Eur J Neurosci 2013, 37: 242–250.
203. Logan RW, Williams WP, III, McClung CA. Circadian rhythms and addiction: mechanistic insights and future directions. Behav.Neurosci. 2014, 128: 387–412.
204. Padiath QS, Paranjpe D, Jain S, Sharma VK. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol Int 2004, 21: 43–55.
205. Akiyama M, Kirihara T, Takahashi S, Minami Y, Yoshinobu Y, Moriya T, et al. Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum. Br J Pharmacol 1999, 128: 1616–1622.
206. Honma K, Honma S. The SCN-independent clocks, methamphetamine and food restriction. Eur J Neurosci 2009, 30: 1707–1717.
207. Gouin JP, Connors J, Kiecolt-Glaser JK, Glaser R, Malarkey WB, Atkinson C, et al. Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord 2010, 126: 161–166.
208. Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, et al. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol 2003, 4: R61.